A recent study into a gene that was previously known to play a part in the development and growth of tumor cells, found that this gene also protected cancerous cells from the effects of chemotherapy. The researchers conducting this study believe that the inhibition of the expression of this gene could provide an effective means [...]

Hospira, Inc., the global leader in the production of generic injectable pharmaceuticals, which also boasts one of the broadest portfolios of generic acute-care and oncology injectables in the world, recently announced the approval of its biosimilar filgrastim product, Nivestim, for distribution in Australia, by the Therapeutic Goods Administration (TGA) of Australia. The TGA granted approval [...]